# Timing of Initiation of LMWH Administration in Pregnant Women With APS

> **NCT02326051** · PHASE4 · COMPLETED · sponsor: **Mohamed Sayed Abdelhafez** · enrollment: 100 (actual)

## Conditions studied

- Recurrent Miscarriage
- Antiphospholipid Syndrome

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT02326051
- **Lead sponsor:** Mohamed Sayed Abdelhafez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-02
- **Final completion:** 2017-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326051, "Timing of Initiation of LMWH Administration in Pregnant Women With APS". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02326051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*